TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: SVR 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 30 day fascial closure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: In-patient mortality and mortality
Endpoint domain: Mortality/survival
Primary endpoint: Health related quality of Life assessed by the Rand 36-Item Health Survey (RAND36)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Independence in activities of daily living assessed by Katz Index of Independence in Activities of Daily Living (Katz ADL)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Percentage of Participants With Tumor Metabolic Response (Reduction of ≥15%) in Positron Emission Tomography With F-18-fluorodeoxyglucose (FDG-PET)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Area under the concentration-time curve after single dose use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak plasma concentration after single dose use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Elimination rate constant after single - dose use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Maximum Aerobic Capacity (VO2max)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Ventilatory Threshold (VT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 2-year support on device
Endpoint domain: Mortality/survival
Primary endpoint: device removal
Endpoint domain: Mortality/survival
Primary endpoint: transplantation recovery
Endpoint domain: Mortality/survival
Primary endpoint: Facial Numbness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Symptoms of Digestive Tract
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Symptoms of Joint System
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Improvement in Richards-Campbell Sleep Questionnaire (RCSQ) scores
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Presence of gonococcal infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Change in total International Index of Erectile Function (IIEF) score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Uterine artery doppler parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Ease of use for EutropinPen Inj.
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Preference for EutropinPen Inj.
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Relative risk of receiving FFP peri-operatively
Endpoint domain: Adverse events/effects
Primary endpoint: Time to complete a physical performance task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rapid Eye Movement (REM) Sleep
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: NEC incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: NEC stage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: NEC outcome
Endpoint domain: Mortality/survival
Primary endpoint: Reduction of RV/LV Ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Major Bleeding and Intracranial Bleeding at 30 Days
Endpoint domain: Adverse events/effects
Primary endpoint: Overall Patient/Caregiver Satisfaction with the Pump
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of participants meeting AFP score criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Frailty composite measure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GU toxicity analysis (CTCAE)
Endpoint domain: Adverse events/effects
Primary endpoint: GI toxicity analysis (CTCAE)
Endpoint domain: Adverse events/effects
Primary endpoint: quality of life questionnaires analysis (EPIC26)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Virological efficacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in product-process assessment of FMS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: success rate of recruitment and retention
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: frequency of ventricular arrhythmias
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Quit Smoking Rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety as expressed by adverse-event reporting
Endpoint domain: Adverse events/effects
Primary endpoint: Cholangiographic Resolution of Bile Leak
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline Parent-Adolescent reciprocity paradigm
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Change from baseline Contextual Assessment of Social Skills
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Peak Height
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gluteal EMG recordings (% of maximal EMG value)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quadriceps EMG recordings (% of maximal EMG value)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Triceps EMG recordings (% of maximal EMG value)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in blood glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: numbers of metastatic lymph node
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: adverse events related to treatment
Endpoint domain: Adverse events/effects
Primary endpoint: plasma NGAL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vital signs (blood pressure, heart rate, respiratory rate, oral body temperature)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Volume of distribution (VT) of [11C] GR205171 in the brain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Generalized Anxiety Disorder (GAD-7) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 1-year renal survival
Endpoint domain: Mortality/survival
Primary endpoint: Increase in percentage of CD4+CD25+foxp3+ cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Diagnostic accuracy of stool FIT plus urine VOC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perception of the Nurse
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Perception of physician
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Perception of family member
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Agitated behavior scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Alcohol withdrawal assessment scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Composite Measure of IXT Control Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bias of proAQT measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of eTNS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Expression levels of TSLP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Size of mediastinal and intraabdominal lymph nodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Composite of death, myocardial infarction, acute coronary syndrome, heart failure hospitalization
Endpoint domain: Mortality/survival
Primary endpoint: rate of endotracheal intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Changes in clinician-rated depression-related symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in self-reported depression-related symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of days with moderate or severe headache
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in health-related physical fitness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level of IBS symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to achieve the maximum observed plasma concentration (Tmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the plasma drug concentration-time curve from time zero to Day 28 post-dose (AUC 0-28)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ever been pregnant
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Sex without using birth control in prior 3 months
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Constant-Murley shoulder assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Volume of distribution of antibiotics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clearance of antibiotics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: patient-perceived health-related Quality of Life
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Ability to Transfer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Transfer Time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain relief after total knee arthroplasty
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BRAC 2-5 type bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Early safety at 30 days
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants with Adverse Events (AE) and Serious Adverse Events (SAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Tumor Objective Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in nutrition knowledge
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in Celiac Disease knowledge
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in intentional behavior related to the social inclusion of people with Celiac condition
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Immunological response rate in PBMC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Proportion of participants with drug resistant mutation loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subject Rating of the Natural Look and Feel of the Lips
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Injector Rating of the Natural Look and Feel of the Lips
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Radiation induced esophagitis
Endpoint domain: Adverse events/effects
Primary endpoint: Radiation induced pneumonitis
Endpoint domain: Adverse events/effects
Primary endpoint: Clinical-pathologic data collection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Rate of symptom improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Joints Per Week
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in Percent Days of Cannabis Use Per Week
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Incidence of complete remission (CR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hematologic improvement (CRp)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of circulating melanoma cells/ml in blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Rate of Clinical Decline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Lumbar Spine BMD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Improvement in agitation and aggression symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in peak VO2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: composite of hospitalizations, deaths during, or within three hours after exercise
Endpoint domain: Mortality/survival
Primary endpoint: IBS Symptom Severity Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Intraoperative and postoperative morbidity
Endpoint domain: Adverse events/effects
Primary endpoint: Mid-expiratory flow (MEF 25-75)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Pulmonary outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Cancer outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Static Foot Posture Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Freedom from biochemical failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in Rickets Severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative Pain Reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: measurement completion rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: loss-to-follow-up
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: exercise session adherence
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Frequency of neck and shoulder pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Heart-rate variability changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fundus autofluorescence surface area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Success factors in ovarian stimulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Composite sedation score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Ex-vivo Cholesterol Deposits
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Numeric Pain Rating Scale Change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Profile of Mood States Scale Tension-Anxiety Subscale Change
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Time from hospital arrival to Percutaneous Coronary Intervention (PCI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Time from hospital arrival to initiation of cooling
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Proportion of subjects achieving target temperature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Sheehan Disability Scale
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Change in DKEFS Trail Making Test - Condition 4
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: change in Maternal depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Adherence to doctor's instructions
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Total Score for Concerns About Recurrence Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Efficacy of repositioning maneuvers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neurophysiological activity changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Metal Ion Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Cyst Recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Door-to-balloon time in patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Markers successful myocardial reperfusion by angiography
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Time from onset of chest pain to artery opening
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of Participants With Adverse Events, Serious Adverse Events and Death
Endpoint domain: Adverse events/effects
Primary endpoint: Change From Baseline in Aortic Distensibility
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change From Baseline in Plaque Burden (Aortic Vessel Wall Area and Carotid Vessel Wall Area)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Accuracy of diagnosing hydronephrosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of Heavy Drinking Days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Weekly Drinks Per Drinking Day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 1-year revision rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Pharmacokinetics (AUClast and Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in liquid intake and output volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cefazolin Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients without catheter-related infection
Endpoint domain: Adverse events/effects
Primary endpoint: RH-Pat score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Investigator assessment of improvement of the clinical picture
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mycological Cure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Minimal Symptoms
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: EQVAS Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: QuickDASH Functional Scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: VAS Pain Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety and tolerability of the study drug
Endpoint domain: Adverse events/effects
Primary endpoint: Age at first sexual intercourse
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Efficacy of avutometinib (VS-6766) in KRAS-G12V NSCLC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of avutometinib (VS-6766) in combination with defactinib in BRAF-MT NSCLC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy in KRAS-other (non-G12V) NSCLC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in periapical radiolucency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Modified Maternal-Fetal Attachment Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: MRI image production
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Meniscal posterior shift
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic accuracy of methylation panel
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum observed plasma concentrations (Cmax) of Naproxen Sodium
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the plasma concentration-vs.-time curves (AUCt)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite event rate of death, non-fatal myocardial infarction (MI), or Target-Vessel Revascularization (TVR)
Endpoint domain: Mortality/survival
Primary endpoint: Horizontal Ridge Width Change in Millimeters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vertical Ridge Height Change in Millimeters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post Operative Pain
Endpoint domain: Adverse events/effects
Primary endpoint: adherence to asthma controller medications
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: development of diabetes type 2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: concentration of PF-04531083 in blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes